# Aquestive Therapeutics, Inc.: Form 8-K, filed Oct 19, 2026

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2026-10-19
- Accepted by EDGAR: Oct 19, 2026, 16:04 ET
- Period: 2026-10-15
- Accession: 0001398733-26-000063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000063/aqst-20261015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000063/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000139873326000063/aqst-20261015.htm

Filed Oct 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001398733-26-000063. Last ingested by Listed: Nov 13, 2026, 00:21 ET. No prices; not investment advice.